These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6220024)

  • 21. Determination of denopamine in human and dog plasma by high-performance liquid chromatography with electrochemical detection.
    Tagawa K; Ueki T; Mizobe M; Noda K; Samejima M
    J Chromatogr; 1990 Aug; 529(2):500-6. PubMed ID: 2229268
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure.
    Uretsky BF; Generalovich T; Verbalis JG; Valdes AM; Reddy PS
    Am J Cardiol; 1986 Jul; 58(1):110-6. PubMed ID: 2942027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology and pharmacokinetics of enoximone.
    Dage RC; Okerholm RA
    Cardiology; 1990; 77 Suppl 3():2-13; discussion 27-33. PubMed ID: 2148277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous determination of nafimidone [1-(2-naphthoylmethyl)imidazole], a new anticonvulsant agent, and a major metabolite in plasma by high-performance liquid chromatography.
    Graham DJ; Eadie J; Leadbetter BM; Metcalf R
    J Chromatogr; 1983 Jun; 275(1):211-6. PubMed ID: 6409915
    [No Abstract]   [Full Text] [Related]  

  • 25. [Solid phase clean-up and determination of vesnarinone in plasma by high performance liquid chromatography].
    Wu S; Wu C
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):106-9. PubMed ID: 1398618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of fenoximone, a new cardiotonic, in healthy subjects.
    Alken RG; Belz GG; Haegele KD; Meinicke T; Schechter PJ
    Clin Pharmacol Ther; 1984 Aug; 36(2):209-16. PubMed ID: 6235081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of enoximone in patients with low ejection fraction undergoing coronary artery bypass graft surgery.
    Oduro A; Latimer RD; Davies A; Jani K
    Br J Clin Pract Suppl; 1988 Dec; 64():50-2. PubMed ID: 2978500
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological comparison of CK-2289, an inodilator agent, with milrinone and enoximone.
    Greenberg SS; Paul J; Luisi A
    Arch Int Pharmacodyn Ther; 1991; 309():103-24. PubMed ID: 1653560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.
    Gilbert EM; Bristow MR; Mason JW
    Am J Cardiol; 1987 Aug; 60(5):57C-62C. PubMed ID: 2956870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiologic response to the inotropic and vasodilator properties of enoximone.
    Janicki JS; Shroff SG; Weber KT
    Am J Cardiol; 1987 Aug; 60(5):15C-20C. PubMed ID: 2956862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
    Installé E; Gonzalez M; Jacquemart JL; Collard P; Roulette F; Pourbaix S; Tremouroux J
    Am J Cardiol; 1987 Aug; 60(5):46C-52C. PubMed ID: 2956868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of a new anti-allergenic agent, 1-[4-[3-[4-[bis-(4-fluorophenyl)hydroxymethyl]-1-piperidinyl] propoxy]-3-methoxyphenyl]ethanone, and its active acidic metabolite in plasma by high-performance liquid chromatography.
    Greene SV; Krebs HA; Lemieux RE; Cheng LK
    J Chromatogr; 1990 May; 527(2):397-405. PubMed ID: 2387886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of a new antiulcer agent, YJA-20379-2, in human plasma and urine by high-performance liquid chromatography.
    Yoon WH; Kim SH; Chung SY; Chang MS; Choi WS; Sohn SK; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Dec; 94(3):317-22. PubMed ID: 9029677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
    Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Enoximone].
    Ventura G
    Medicina (Firenze); 1990; 10(2):191-3. PubMed ID: 2148796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043.
    Endoh M; Yanagisawa T; Morita T; Taira N
    J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy.
    Weber KT; Janicki JS; Jain MC
    Am J Cardiol; 1986 Sep; 58(7):589-95. PubMed ID: 2944369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of intravenous enoximone in dialysis patients.
    Fiegel P; Trenk D; Jaehnchen E; Dieterich HA
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S20-3. PubMed ID: 2480480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of intravenous enoximone following coronary artery bypass surgery.
    Oduro A; Latimer RD; Davies A
    Cardiology; 1990; 77 Suppl 3():42-5; discussion 62-7. PubMed ID: 2148279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversed-phase chromatography of fenflumizole, a new potential anti-inflammatory agent, and its application in pharmacokinetic studies in rat, dog and man.
    Midskov C
    J Chromatogr; 1983 Nov; 278(1):109-15. PubMed ID: 6662868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.